SPADAFORE DOMINIC J 4

4 · SOMANETICS CORP · Filed Jul 28, 2010

Form 4

Period: 2010-07-27

Sr. VP US Sales and Marketing

Transactions

Disposition to Issuer
Employee stock option (right to buy)
2010-07-27$22.70/sh−55,000$1,248,500→ 0 total
Exercise: $2.30Exp: 2012-08-01→ Common Shares (55,000 underlying)
Disposition to Issuer
Employee stock option (right to buy)
2010-07-27$6.94/sh−18,000$124,920→ 0 total
Exercise: $18.06Exp: 2016-06-29→ Common Shares (18,000 underlying)
Disposition from Tender
Common Shares
2010-07-27$25.00/sh−38,900$972,500→ 0 total
Disposition to Issuer
Employee stock option (right to buy)
2010-07-27$21.11/sh−36,000$759,960→ 0 total
Exercise: $3.89Exp: 2013-08-13→ Common Shares (36,000 underlying)
Disposition to Issuer
Employee sotck option (right to buy)
2010-07-27$11.45/sh−11,680$133,736→ 0 total
Exercise: $13.55From: 2005-11-30Exp: 2015-04-21→ Common Shares (11,680 underlying)
Disposition to Issuer
Employee stock option (right to buy)
2010-07-27$12.39/sh−18,000$223,020→ 0 total
Exercise: $12.61Exp: 2018-03-20→ Common Shares (18,000 underlying)

Footnotes (4)

[F1]The option vested in three equal annual installments commencing 8/1/03
[F2]The option vested in three equal annual installments commencing 8/13/04 and the unvested portion vested 100% on 11/30/05
[F3]The option vested in five equal annual installments beginning on 6/29/07 and the unvested portion of the option became exercisable upon change of control pursuant to acceptance of the shares in the tender offer pursuant to the agreement and plan of merger between Somanetics and Covidien announced on June 16, 2010
[F4]The option vested in five equal annual installments beginning on 3/20/09 and the unvested portion of the option became exercisable upon change of control pursuant to acceptance of the shares in the tender offer pursuant to the agreement and plan of merger between Somanetics and Covidien announced on June 16, 2010

Documents

1 file